The Benefits and Risks of Long-Term Anticoagulation After Venous Thromboembolism

Eric A. Dietrich; Kyle Davis

首页> 外文期刊>Consultant >The Benefits and Risks of Long-Term Anticoagulation After Venous Thromboembolism

【24h】

The Benefits and Risks of Long-Term Anticoagulation After Venous Thromboembolism

机译：静脉血栓栓塞后长期抗凝治疗的益处和风险

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Patients with venous thromboembolism (VTE) events are commonly encountered in primary care, and the acute treatment with anticoagulants (warfarin or novitamin K oral antagonists NOACs) is well established.

机译：静脉血栓栓塞（venous thromboembolism， VTE）事件患者常见于初级保健机构，抗凝剂（华法林或非维生素 K 口服拮抗剂 [NOAC]）的急性治疗已成熟。

著录项

来源
《Consultant》 |2016年第8期|749-750|共2页
作者
Eric A. Dietrich; Kyle Davis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation Response [J] . Carrier Marc, Le Gal Gregoire Annals of Internal Medicine . 2022,第4期

机译：Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation Response
2. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study. [J] . Grégoire Le Gal, Michael J Kovacs, Laurent BertolettiFrancis CouturaudCarole DennieAndrew M HirschMenno V HuismanFrederikus A KlokNoémie KraaijpoelRanjeeta MallickAmanda PecarskieElena PenaPenny PhillipsIsabelle PichonTim RamsayMarc RighiniMarc A RodgerPierre-Marie RoyOlivier SanchezJeannot SchmidtSam SchulmanSudeep ShivakumarAlbert Trinh-DucRachel VerdetUlric VinsonneauPhilip WellsCynthia WuErik YeoMarc Carrier Annals of Internal Medicine . 2022,第1期

机译：Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study.
3. Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage [J] . Thuhien Nguyen, Sharma Monisha, Crooks PatrickPatel Pratik VBonow Robert H.Creutzfeldt Claire J.Wahlster Sarah British journal of neurosurgery . 2022,第2期

机译：Between Scylla and Charybdis: risks of early therapeutic anticoagulation for venous thromboembolism after acute intracranial hemorrhage
4. The CM@Risk Contractor:In the Driver's Seat of the CM@Risk Team [C] . Mr. Richard D. Smith 2005 AACE International Transactions . 2005

机译：CM @ Risk承包商：在CM @ Risk团队的驾驶席上
5. 从上市公司股权质押行为分析企业的潜在风险和公司治理 =Analyzing the Potential Risks and Corporate Governance of Enterprises from the Equity Pledge of Listed Companies [D] . Chen, Wei. 2020

机译：从上市公司股权质押行为分析企业的潜在风险和公司治理 =Analyzing the Potential Risks and Corporate Governance of Enterprises from the Equity Pledge of Listed Companies
6. Posttransplant reduction in preexisting donor‐specific antibody levels after belatacept‐ versus cyclosporine‐based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT‐EXT [O] . R. A. Bray, H. M. Gebel, R. Townsend, -1

机译：贝拉西普与环孢素免疫抑制后移植后供体特异性抗体水平的降低：BENEFIT和BENEFIT-EXT的事后分析
7. Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-venous thromboembolism study--methodological implications for clinical trials. [O] . Raskob, G., Büller, H., Prins, M., 2013

机译：Edoxaban用于长期治疗静脉血栓栓塞：Hokusai-venous thromboembolism研究的基本原理和设计 - 临床试验的方法学意义。
8. Radiological risk evaluation for risk-based design criteria of the multiple canister overpack packaging [R] . Green, J. R. 1996

机译：Radiological risk evaluation for risk-based design criteria of the multiple canister overpack packaging

The Benefits and Risks of Long-Term Anticoagulation After Venous Thromboembolism

摘要

著录项

相似文献

相关主题

期刊订阅